4 Biotechs Facing Do-or-Die Catalysts in December Post author:Sam Post published:December 5, 2017 Post category:BioPharma As 2018 winds down, it’s not over for some biopharma companies. Source: BioSpace You Might Also Like Avoid These 3 Biotech Stocks Like the Plague February 28, 2017 Hill-Rom To Host Fiscal Fourth Quarter 2017 Earnings Conference Call And Webcast September 28, 2017 Generation Bio Emerges With $25M and Former Sobi CEO as Its New Leader January 3, 2018
